Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Revenue 2022–2025
Axsome Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Axsome Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 191.2 M, a 57.42% increase year-over-year.
- Axsome Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 633.7 M, a 95.15% increase year-over-year.
- Axsome Therapeutics, Inc. annual revenue for 2025 was 638.5 M, a 65.55% increase from 2024.
- Axsome Therapeutics, Inc. annual revenue for 2024 was 385.7 M, a 42.53% increase from 2023.
- Axsome Therapeutics, Inc. annual revenue for 2023 was 270.6 M, a 440.80% increase from 2022.
- Axsome Therapeutics, Inc. annual revenue for 2022 was 50.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Axsome Therapeutics, Inc. Revenue — FAQ
Axsome Therapeutics, Inc. (AXSM) revenue over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Axsome Therapeutics, Inc.'s revenue?
Axsome Therapeutics, Inc. (AXSM) reported revenue of $638M for fiscal 2025.
Where can I see AXSM's revenue history?
The chart and table above show Axsome Therapeutics, Inc.'s revenue by year and by quarter, including the growth rate.